Return to Listing

1 result(s) for

PI Name Protocol # Title
Brian Druker IRB00009554 A single-arm, multicenter, nilotinib treatment-free remission study in patients with BCR-ABL1 positive Chronic Myelogenous Leukemia in chronic phase who have achieved durable minimal residual disease (MRD) status on first line nilotinib treatment.
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080